Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
/
Date17 Feb 2020
Email Print Friendly Share RADNOR, Pa., Feb. 14, 2020 (GLOBE NEWSWIRE) — Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”, “Marinus”), a biopharmaceutical company dedicated to the... Read More →
Teleflex Incorporated Announces Worldwide Voluntary Recall of COMFORT FLO® Humidification System
/
Date16 Feb 2020
Email Print Friendly Share WAYNE, Pa., Feb. 14, 2020 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX), a global provider of medical technologies for critical care... Read More →
FDA Approves Agile Therapeutics, Inc.’s Twirla® (levonorgestrel and ethinyl estradiol) Transdermal System – A New Weekly Contraceptive Patch Delivering a 30 mcg Daily Dose of Estrogen and 120 mcg Daily Dose of Progestin
/
Date15 Feb 2020
Email Print Friendly Share Twirla® is a new non-daily, non-invasive contraceptive approved in the U.S. PRINCETON, N.J., Feb. 14, 2020 (GLOBE NEWSWIRE) — Agile Therapeutics,... Read More →
Bergen New Bridge Medical Center Seeks to Address Social Determinates of Health and Eliminate Barriers to Care
/
Date14 Feb 2020
Email Print Friendly Share Paramus, NJ, Feb. 13, 2020 (GLOBE NEWSWIRE) — February 13, 2020 – Paramus, NJ – Bergen New Bridge Medical Center released... Read More →
Arthroscopic Devices Market To Reach USD 7.05 Billion By 2026 | Reports And Data
/
Date13 Feb 2020
Email Print Friendly Share New York, Feb. 12, 2020 (GLOBE NEWSWIRE) — According to the current analysis of Reports and Data, the global Arthroscopic Devices... Read More →
Lilly et Incyte dévoilent des premiers résultats positifs pour l’étude nord-américaine de phase III (BREEZE-AD5) sur le baricitinib, un inhibiteur sélectif des protéines JAK, destiné au traitement oral de la dermite atopique modérée ou sévère
/
Date12 Feb 2020
Email Print Friendly Share Le baricitinib a satisfait au critère d’évaluation principal de l’étude, soit une réduction d’au moins 75 % de l’inflammation cutanée, et aux critères... Read More →
Mitch Gould and Nutritional Products International’s Enters Second Decade of ‘Evolution of Distribution’
/
Date11 Feb 2020
Email Print Friendly Share Mitch Gould, the founder of NPI, is a third-generation retail distribution and manufacturing professional. Gould, known as a global marketing guru,... Read More →
Updates from Passengers Phil and Gay Courter on the Diamond Princess Quarantine
/
Date10 Feb 2020
Email Print Friendly Share YOKOHAMA, Japan, Feb. 09, 2020 (GLOBE NEWSWIRE) — Phil and Gay Courter are in their fourth day of quarantine aboard the... Read More →
Adverum Biotechnologies Reports New Interim Data from Cohorts 1 and 2 of OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD at Angiogenesis, Exudation, and Degeneration 2020
/
Date09 Feb 2020
Email Print Friendly Share — Robust efficacy with evidence of a dose response —— 6/6 patients rescue-injection-free in cohort 1, with 3 patients at 52... Read More →
Kalytera Announces New Payments Agreement with the Salzman Group of Israel
/
Date08 Feb 2020
Email Print Friendly Share SAN FRANCISCO and TEL AVIV, Israel, Feb. 07, 2020 (GLOBE NEWSWIRE) — Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF)... Read More →